Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080596990> ?p ?o ?g. }
Showing items 1 to 74 of
74
with 100 items per page.
- W2080596990 abstract "Background Fampridine is indicated for the improvement of walking in patients with multiple sclerosis (MS) (EDSS 4–7). Purpose To assess the effectiveness, undesirable effects and adherence to fampridine. Material and methods A 30-month retrospective study was conducted, including MS patients receiving fampridine 10 mg BID. Medical records were reviewed for data on Timed 25-Foot Walk (T25FW) and 12-item MS walking scale (MSWS-12), from baseline over a 24-month period (screening at baseline, day 15, months 3, 12, 18 and 24). Adverse events (AEs) were also recorded from medical records and hospital admissions and emergency department (ED) visits were analysed in order to identify suspected AEs. The adherence rate was calculated from pharmacy dispensing records. Results 19 patients (68.4% women), mean age 61.9 (40–80) years with different forms of MS (relapsing remitting 26.3%, primary progressive 42.1% and secondary progressive 42.1%) were included. Effectiveness data are shown in Table 1. 58.9% of patients (11/19) were hospitalised or visited the ED. The AEs identified were mostly urinary tract infections (37.3%) and dizziness, causing falls, (36.4%) (causal relationship not established). A high level of adherence (97.5%) was achieved. Conclusion More than a half of the patients treated with fampridine experienced a clinically relevant improvement in walking ability (increase of over 20% in T25FW and MSWS-12 scale reduction ≥6), which was sustained for at least 24 months. Side effects were mild and acceptable. References and/or Acknowledgements 1 Goodman AD, Brown TR, Krupp LB, et al . Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet 2009;373:732–8 No conflict of interest." @default.
- W2080596990 created "2016-06-24" @default.
- W2080596990 creator A5025044630 @default.
- W2080596990 creator A5042048482 @default.
- W2080596990 creator A5063540717 @default.
- W2080596990 creator A5073484928 @default.
- W2080596990 creator A5085807391 @default.
- W2080596990 creator A5013330102 @default.
- W2080596990 date "2015-03-01" @default.
- W2080596990 modified "2023-09-27" @default.
- W2080596990 title "CP-158 Our experience with fampridine in patients with multiple sclerosis after 2 years of treatment: Abstract CP-158 Table 1" @default.
- W2080596990 doi "https://doi.org/10.1136/ejhpharm-2015-000639.151" @default.
- W2080596990 hasPublicationYear "2015" @default.
- W2080596990 type Work @default.
- W2080596990 sameAs 2080596990 @default.
- W2080596990 citedByCount "0" @default.
- W2080596990 crossrefType "journal-article" @default.
- W2080596990 hasAuthorship W2080596990A5013330102 @default.
- W2080596990 hasAuthorship W2080596990A5025044630 @default.
- W2080596990 hasAuthorship W2080596990A5042048482 @default.
- W2080596990 hasAuthorship W2080596990A5063540717 @default.
- W2080596990 hasAuthorship W2080596990A5073484928 @default.
- W2080596990 hasAuthorship W2080596990A5085807391 @default.
- W2080596990 hasConcept C104863432 @default.
- W2080596990 hasConcept C118552586 @default.
- W2080596990 hasConcept C126322002 @default.
- W2080596990 hasConcept C167135981 @default.
- W2080596990 hasConcept C1862650 @default.
- W2080596990 hasConcept C194828623 @default.
- W2080596990 hasConcept C195910791 @default.
- W2080596990 hasConcept C197934379 @default.
- W2080596990 hasConcept C2780640218 @default.
- W2080596990 hasConcept C2780724011 @default.
- W2080596990 hasConcept C512399662 @default.
- W2080596990 hasConcept C71924100 @default.
- W2080596990 hasConceptScore W2080596990C104863432 @default.
- W2080596990 hasConceptScore W2080596990C118552586 @default.
- W2080596990 hasConceptScore W2080596990C126322002 @default.
- W2080596990 hasConceptScore W2080596990C167135981 @default.
- W2080596990 hasConceptScore W2080596990C1862650 @default.
- W2080596990 hasConceptScore W2080596990C194828623 @default.
- W2080596990 hasConceptScore W2080596990C195910791 @default.
- W2080596990 hasConceptScore W2080596990C197934379 @default.
- W2080596990 hasConceptScore W2080596990C2780640218 @default.
- W2080596990 hasConceptScore W2080596990C2780724011 @default.
- W2080596990 hasConceptScore W2080596990C512399662 @default.
- W2080596990 hasConceptScore W2080596990C71924100 @default.
- W2080596990 hasLocation W20805969901 @default.
- W2080596990 hasOpenAccess W2080596990 @default.
- W2080596990 hasPrimaryLocation W20805969901 @default.
- W2080596990 hasRelatedWork W1971433460 @default.
- W2080596990 hasRelatedWork W1980071637 @default.
- W2080596990 hasRelatedWork W2004229234 @default.
- W2080596990 hasRelatedWork W2004916007 @default.
- W2080596990 hasRelatedWork W2005052817 @default.
- W2080596990 hasRelatedWork W2073970700 @default.
- W2080596990 hasRelatedWork W2115538350 @default.
- W2080596990 hasRelatedWork W2129406761 @default.
- W2080596990 hasRelatedWork W2133755641 @default.
- W2080596990 hasRelatedWork W2314982100 @default.
- W2080596990 hasRelatedWork W2319658363 @default.
- W2080596990 hasRelatedWork W2524199151 @default.
- W2080596990 hasRelatedWork W2740278081 @default.
- W2080596990 hasRelatedWork W2899877222 @default.
- W2080596990 hasRelatedWork W2914099159 @default.
- W2080596990 hasRelatedWork W2947497059 @default.
- W2080596990 hasRelatedWork W3028575358 @default.
- W2080596990 hasRelatedWork W3106029492 @default.
- W2080596990 hasRelatedWork W3126716594 @default.
- W2080596990 hasRelatedWork W2201650993 @default.
- W2080596990 isParatext "false" @default.
- W2080596990 isRetracted "false" @default.
- W2080596990 magId "2080596990" @default.
- W2080596990 workType "article" @default.